Financials

  • Market Capitalization 3.11 B
  • Employee 370
  • Founded 2016
  • CEO N/A
  • Website www.tarsusrx.com
  • Headquarter Delaware, United States
  • FIGI BBG00RB9BNQ7
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-51.5
Rapporto prezzo/fatturato
7.58

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1607
ACAD
ACADIA Pharmaceuticals Inc. - Common Stock
18.62 USD-4.07%-5.00%-32.32%-8.77%3.21 B USD
1624
VKTX
Viking Therapeutics, Inc. - Common Stock
26.65 USD-5.96%-6.00%-14.61%-20.73%3.11 B USD
1629
CELC
Celcuity Inc. - Common Stock
63.19 USD-4.04%-10.39%-24.46%+34.82%3.09 B USD
1661
AMLX
Amylyx Pharmaceuticals, Inc. - Common Stock
26.85 USD-2.29%-3.14%-19.18%+83.90%2.99 B USD

Notizie